Transitional Treatment of Adolescents in Family Therapy (Transitions)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Oregon Research Institute
ClinicalTrials.gov Identifier:
NCT00680381
First received: May 16, 2008
Last updated: May 22, 2013
Last verified: May 2013
  Purpose

The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.


Condition Intervention Phase
Substance Abuse
Behavioral: MTI, Minimal Transitional Intervention
Behavioral: GTI, Group Transitional Intervention
Behavioral: STI, Systems Transitions Intervention
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Transitional Treatment of Adolescents in Family Therapy

Further study details as provided by Oregon Research Institute:

Primary Outcome Measures:
  • Drug use levels for adolescents who have received family therapy and one of the three aftercare regimens [ Time Frame: pretx and 6 wks, 4 , 7 and 12 mos. post initial therapy session ] [ Designated as safety issue: No ]

Estimated Enrollment: 90
Study Start Date: January 2004
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly therapist phone calls for eight weeks.
Behavioral: MTI, Minimal Transitional Intervention
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
Active Comparator: 2
Following 12 weeks of FFT, weekly one-hour group therapy for eight weeks
Behavioral: GTI, Group Transitional Intervention
Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
Active Comparator: 3
Following 12 weeks of FFT, an eight-week, customized series of therapist visits with the adolescent, family, teachers, coaches and others who can support the adolescent's reduced level of drug use.
Behavioral: STI, Systems Transitions Intervention
Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.

  Eligibility

Ages Eligible for Study:   13 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. At least one parent, step-parent, or surrogate parent willing to participate in the study
  2. 13 to 18 years if age
  3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence
  4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND
  5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria:

  1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
  2. Adolescent deemed dangerous to self or others during evaluation
  3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)
  4. Adolescent already has participated in treatment project at CFAR; AND
  5. A sibling is already participating in project.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00680381

Locations
United States, New Mexico
Oregon Res. Inst. Center for Family & Adolescent Research (CFAR)
Albuquerque, New Mexico, United States, 87102
Sponsors and Collaborators
Oregon Research Institute
Investigators
Principal Investigator: Holly B. Waldron, Ph.D. Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)
  More Information

No publications provided

Responsible Party: Oregon Research Institute
ClinicalTrials.gov Identifier: NCT00680381     History of Changes
Other Study ID Numbers: DA15762, R01DA15762
Study First Received: May 16, 2008
Last Updated: May 22, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Oregon Research Institute:
adolescent substance abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 23, 2014